Brandes Investment Partners, LP Takeda Pharmaceutical CO LTD Transaction History
Brandes Investment Partners, LP
- $10.5 Billion
- Q2 2025
A detailed history of Brandes Investment Partners, LP transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Brandes Investment Partners, LP holds 3,712,278 shares of TAK stock, worth $54.3 Million. This represents 0.54% of its overall portfolio holdings.
Number of Shares
3,712,278
Previous 3,504,142
5.94%
Holding current value
$54.3 Million
Previous $52.1 Million
10.14%
% of portfolio
0.54%
Previous 0.57%
Shares
27 transactions
Others Institutions Holding TAK
# of Institutions
376Shares Held
67.8MCall Options Held
1.72MPut Options Held
186K-
Capital Research Global Investors Los Angeles, CA13.3MShares$195 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.7MShares$83.4 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY5.32MShares$77.8 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.43MShares$50.2 Million0.1% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.3MShares$48.3 Million0.07% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $45.5B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...